amphetamine has been researched along with vasoactive intestinal peptide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goiny, M; Uvnäs-Moberg, K | 1 |
Clemens, JA; Shaar, CJ; Smalstig, EB | 1 |
Copinga, S; Grol, CJ; Homan, EJ; Jackson, DM; Unelius, L; Wikström, HV | 1 |
Bowyer, JF; George, NI; Patterson, TA; Thomas, M | 1 |
4 other study(ies) available for amphetamine and vasoactive intestinal peptide
Article | Year |
---|---|
Effects of dopaminomimetics on the secretion of VIP-like immunoreactivity in conscious dogs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Apomorphine; Benzazepines; Dogs; Ergolines; Nitroglycerin; Pergolide; Piperidines; Prazosin; Receptors, Dopamine; Somatostatin; Vasoactive Intestinal Peptide | 1986 |
Dopamine, PIF, and other regulators of prolactin secretion.
Topics: Amphetamine; Animals; Dopamine; Dose-Response Relationship, Drug; Humans; Hypothalamus; Muscimol; Neurotransmitter Agents; Pituitary Gland; Prolactin; Prolactin Release-Inhibiting Factors; Rats; Vasoactive Intestinal Peptide | 1980 |
Synthesis and Pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT.
Topics: Amphetamine; Animals; Antipsychotic Agents; Benzamides; Catalepsy; Cells, Cultured; Cyclic AMP; Dopamine Agents; Humans; Inhibitory Concentration 50; Isomerism; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Remoxipride; Serotonin Agents; Structure-Activity Relationship; Tetrahydronaphthalenes; Vasoactive Intestinal Peptide | 1999 |
Amphetamine and environmentally induced hyperthermia differentially alter the expression of genes regulating vascular tone and angiogenesis in the meninges and associated vasculature.
Topics: Amphetamine; Animals; Blood Vessels; Body Temperature; Brain; Central Nervous System Stimulants; Connective Tissue Growth Factor; Cytokines; Dose-Response Relationship, Drug; Environment; Fever; Gene Expression Profiling; Gene Expression Regulation; HSP72 Heat-Shock Proteins; Male; Meninges; Neovascularization, Physiologic; Oligonucleotide Array Sequence Analysis; Rats; Rats, Sprague-Dawley; Time Factors; Vasoactive Intestinal Peptide | 2009 |